<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33517839</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2150-5608</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Virulence</Title><ISOAbbreviation>Virulence</ISOAbbreviation></Journal><ArticleTitle>Sox4 represses host innate immunity to facilitate pathogen infection by hijacking the TLR signaling networks.</ArticleTitle><Pagination><StartPage>704</StartPage><EndPage>722</EndPage><MedlinePgn>704-722</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21505594.2021.1882775</ELocationID><Abstract><AbstractText>Toll-like receptors (TLRs) are essential for the protection of the host from pathogen infections by initiating the integration of contextual cues to regulate inflammation and immunity. However, without tightly controlled immune responses, the host will be subjected to detrimental outcomes. Therefore, it is important to balance the positive and negative regulations of TLRs to eliminate pathogen infection, yet avert harmful immunological consequences. This study revealed a distinct mechanism underlying the regulation of the TLR network. The expression of sex-determining region Y-box 4 (Sox4) is induced by virus infection in viral infected patients and cultured cells, which subsequently represses the TLR signaling network to facilitate viral replication at multiple levels by a distinct mechanism. Briefly, Sox4 inhibits the production of myeloid differentiation primary response gene 88 (MyD88) and most of the TLRs by binding to their promoters to attenuate gene transcription. In addition, Sox4 blocks the activities of the TLR/MyD88/IRAK4/TAK1 and TLR/TRIF/TRAF3/TBK1 pathways by repressing their key components. Moreover, Sox4 represses the activation of the nuclear factor kappa-B (NF-&#x3ba;B) through interacting with IKK&#x3b1;/&#x3b1;, and attenuates NF-kB and IFN regulatory factors 3/7 (IRF3/7) abundances by promoting protein degradation. All these contributed to the down-regulation of interferons (IFNs) and IFN-stimulated gene (ISG) expression, leading to facilitate the viral replications. Therefore, we reveal a distinct mechanism by which viral pathogens evade host innate immunity and discover a key regulator in host defense.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University , Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Jiayin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University , Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wenbiao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yongkui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xulin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qiwei</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Kailang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University , Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Weiyong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jianguo</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8326-2895</Identifier><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University , Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Virulence</MedlineTA><NlmUniqueID>101531386</NlmUniqueID><ISSNLinking>2150-5594</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053594">Myeloid Differentiation Factor 88</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C083431">SOX4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055751">SOXC Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051193">Toll-Like Receptors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056945" MajorTopicYN="N">Hep G2 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053594" MajorTopicYN="N">Myeloid Differentiation Factor 88</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055751" MajorTopicYN="N">SOXC Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051193" MajorTopicYN="N">Toll-Like Receptors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="N">Viruses</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">HCV</Keyword><Keyword MajorTopicYN="N">IAV</Keyword><Keyword MajorTopicYN="N">IFN</Keyword><Keyword MajorTopicYN="N">IFN regulatory factors 3/7</Keyword><Keyword MajorTopicYN="N">IFN-stimulated gene</Keyword><Keyword MajorTopicYN="N">IRF3/7</Keyword><Keyword MajorTopicYN="N">ISG</Keyword><Keyword MajorTopicYN="N">MyD88</Keyword><Keyword MajorTopicYN="N">SEV</Keyword><Keyword MajorTopicYN="N">Sox4</Keyword><Keyword MajorTopicYN="N">TLRS</Keyword><Keyword MajorTopicYN="N">Toll-like receptors</Keyword><Keyword MajorTopicYN="N">VSV</Keyword><Keyword MajorTopicYN="N">hepatitis C virus</Keyword><Keyword MajorTopicYN="N">influenza A virus</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">myeloid differentiation primary response gene 88</Keyword><Keyword MajorTopicYN="N">sendai virus</Keyword><Keyword MajorTopicYN="N">sex-determining region Y-box 4</Keyword><Keyword MajorTopicYN="N">vesicular stomatitis virus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>1</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33517839</ArticleId><ArticleId IdType="pmc">PMC7894441</ArticleId><ArticleId IdType="doi">10.1080/21505594.2021.1882775</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pestka S, Langer JA, Zoon KC, et al. Interferons and their actions. Annu Rev Biochem. 1987;56(1):727&#x2013;777.</Citation><ArticleIdList><ArticleId IdType="pubmed">2441659</ArticleId></ArticleIdList></Reference><Reference><Citation>Aderem A, Ulevitch RJ.. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406:782&#x2013;787.</Citation><ArticleIdList><ArticleId IdType="pubmed">10963608</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller U, Steinhoff U, Reis LF, et al. Functional role of type I and type II interferons in antiviral defense. Science. 1994;264(5167):1918&#x2013;1921.</Citation><ArticleIdList><ArticleId IdType="pubmed">8009221</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev. 2001;14:778&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89003</ArticleId><ArticleId IdType="pubmed">11585785</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014;32(1):513&#x2013;545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4313732</ArticleId><ArticleId IdType="pubmed">24555472</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pubmed">15229469</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34(5):637&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pubmed">21616434</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S. Toll-like receptors and innate immunity. Adv Immunol. 2001;78:1&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">11432202</ArticleId></ArticleIdList></Reference><Reference><Citation>Horng T, Barton GM, Flavell RA, et al. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature. 2002;420(6913):329&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pubmed">12447442</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M, Sato S, Hemmi H, et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature. 2002;420(6913):324&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pubmed">12447441</ArticleId></ArticleIdList></Reference><Reference><Citation>Creagh EM, O&#x2019;Neill LA. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 2006;27(8):352&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">16807108</ArticleId></ArticleIdList></Reference><Reference><Citation>Miggin SM, O&#x2019;Neill LA. New insights into the regulation of TLR signaling. J Leukoc Biol. 2006;80(2):220&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">16698941</ArticleId></ArticleIdList></Reference><Reference><Citation>Carty M, Goodbody R, Schroder M, et al. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol. 2006;7(10):1074&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pubmed">16964262</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol. 2006;117(5):979&#x2013;987.</Citation><ArticleIdList><ArticleId IdType="pubmed">16675322</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesche H, Henzel WJ, Shillinglaw W, et al. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity. 1997;7(6):837&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pubmed">9430229</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssens S, Beyaert R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell. 2003;11(2):293&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">12620219</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Strelow A, Fontana EJ, et al. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci U S A. 2002;99(8):5567&#x2013;5572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122810</ArticleId><ArticleId IdType="pubmed">11960013</ArticleId></ArticleIdList></Reference><Reference><Citation>Swantek JL, Tsen MF, Cobb MH, et al. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J Immunol. 2000;164(8):4301&#x2013;4306.</Citation><ArticleIdList><ArticleId IdType="pubmed">10754329</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng L, Wang C, Spencer E, et al. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 2000;103(2):351&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">11057907</ArticleId></ArticleIdList></Reference><Reference><Citation>Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene. 1999;18(49):6867&#x2013;6874.</Citation><ArticleIdList><ArticleId IdType="pubmed">10602462</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004;25(6):280&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">15145317</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato S, Sugiyama M, Yamamoto M, et al. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol. 2003;171(8):4304&#x2013;4310.</Citation><ArticleIdList><ArticleId IdType="pubmed">14530355</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang T, Mansell A. The negative regulation of Toll-like receptor and associated pathways. Immunol Cell Biol. 2007;85(6):425&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">17621314</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunemann A, Rowe M, Nadal D. Innate immune recognition of EBV. Curr Top Microbiol Immunol. 2015;391:265&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pubmed">26428378</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacini L, Savini C, Ghittoni R, et al. Down-regulation of toll-like receptor 9 expression by beta human papillomavirus type 38 and implications for cell cycle control. J Virol. 2015;89(22):11396&#x2013;11405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4645680</ArticleId><ArticleId IdType="pubmed">26339055</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtale G, Mirolo M, Renzi TA, et al. Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b. Proc Natl Acad Sci U S A. 2013;110(28):11499&#x2013;11504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3710884</ArticleId><ArticleId IdType="pubmed">23798430</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Chen J, Wang H, et al. HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. PLoS Pathog. 2013;9(4):e1003248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3635988</ArticleId><ArticleId IdType="pubmed">23633945</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowles J, Schepers G, Koopman P. Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol. 2000;227(2):239&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">11071752</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley VR, Jackson DI, Hextall PJ, et al. DNA binding activity of recombinant SRY from normal males and XY females. Science. 1992;255(5043):453&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">1734522</ArticleId></ArticleIdList></Reference><Reference><Citation>Jauch R, Ng CK, Narasimhan K, et al. The crystal structure of the Sox4 HMG domain-DNA complex suggests a mechanism for positional interdependence in DNA recognition. Biochem J. 2012;443(1):39&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">22181698</ArticleId></ArticleIdList></Reference><Reference><Citation>Nissen-Meyer LS, Jemtland R, Gautvik VT, et al. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice. J Cell Sci. 2007;120(16):2785&#x2013;2795.</Citation><ArticleIdList><ArticleId IdType="pubmed">17652162</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilham MW, Oosterwegel MA, Moerer P, et al. Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature. 1996;380(6576):711&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pubmed">8614465</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergsland M, Werme M, Malewicz M, et al. The establishment of neuronal properties is controlled by Sox4 and Sox11. Genes Dev. 2006;20(24):3475&#x2013;3486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1698453</ArticleId><ArticleId IdType="pubmed">17182872</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattaram P, Penzo-Mendez A, Sock E, et al. Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors. Nat Commun. 2010;1(1):9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2892298</ArticleId><ArticleId IdType="pubmed">20596238</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman RS, Bangur CS, Zasloff EJ, et al. Molecular and immunological evaluation of the transcription factor SOX-4 as a lung tumor vaccine antigen. J Immunol. 2004;172(5):3319&#x2013;3327.</Citation><ArticleIdList><ArticleId IdType="pubmed">14978140</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno CS. The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways. Am J Pathol. 2010;176(2):518&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2808058</ArticleId><ArticleId IdType="pubmed">20019190</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J, Zheng Y, Guo X, et al. Hepatitis B virus replication and sex-determining region Y box 4 production are tightly controlled by a novel positive feedback mechanism. Sci Rep. 2015;5(1):10066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4429541</ArticleId><ArticleId IdType="pubmed">25970172</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Cheng X, Yang X, et al. Early growth response-1 facilitates enterovirus 71 replication by direct binding to the viral genome RNA. Int J Biochem Cell Biol. 2015;62:36&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">25724735</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Yan Q, Lu G, et al. Several residues within the N-terminal arm of vesicular stomatitis virus nucleoprotein play a critical role in protecting viral RNA from nuclease digestion. Virology. 2015;478:9&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">25682471</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Cao Z, Chen J, et al. Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signaling. J Biol Chem. 2012;287(15):11899&#x2013;11910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3320938</ArticleId><ArticleId IdType="pubmed">22343630</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Hao Q, Peng N, et al. Major vault protein: a virus-induced host factor against viral replication through the induction of type-I interferon. Hepatology. 2012;56(1):57&#x2013;66</Citation><ArticleIdList><ArticleId IdType="pubmed">22318991</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina PP, Castillo SD, Blanco S, et al. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer. Hum Mol Genet. 2009;18(7):1343&#x2013;1352.</Citation><ArticleIdList><ArticleId IdType="pubmed">19153074</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006;6(9):644&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pubmed">16932750</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird PI, Trapani JA, Villadangos JA. Endolysosomal proteases and their inhibitors in immunity. Nat Rev Immunol. 2009;9(12):871&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pubmed">19935806</ArticleId></ArticleIdList></Reference><Reference><Citation>He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009;43(1):67&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2831538</ArticleId><ArticleId IdType="pubmed">19653858</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgs R, Ni Gabhann J, Ben Larbi N, et al. The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J Immunol. 2008;181(3):1780&#x2013;1786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2824853</ArticleId><ArticleId IdType="pubmed">18641315</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian C, Cao X. Regulation of Toll-like receptor signaling pathways in innate immune responses. Ann N Y Acad Sci. 2013;1283(1):67&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">23163321</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YY, Liu LJ, Zhong B, et al. WDR5 is essential for assembly of the VISA-associated signaling complex and virus-triggered IRF3 and NF-kappaB activation. Proc Natl Acad Sci U S A. 2010;107(2):815&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2818949</ArticleId><ArticleId IdType="pubmed">20080758</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Wetering M, Oosterwegel M, van Norren K,A, et al. Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. Embo J. 1993;12:3847&#x2013;3854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC413668</ArticleId><ArticleId IdType="pubmed">8404853</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K, Kaisho T, Akira S. TOLL-LIKRECEPTORS. Annu Rev Immunol. 2003;21(1):335&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">12524386</ArticleId></ArticleIdList></Reference><Reference><Citation>An H, Qian C, Cao X. Regulation of Toll-like receptor signaling in the innate immunity. Sc. China Life Sci. 2010;53(1):34&#x2013;43. .</Citation><ArticleIdList><ArticleId IdType="pubmed">20596954</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama S, Ishii KJ, Coban C, et al. Innate immune response to viral infection. Cytokine. 2008;43(3):336&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">18694646</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">16497588</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbalat R, Ewald SE, Mouchess ML, et al. Nucleic acid recognition by the innate immune system. Annu Rev Immunol. 2011;29(1):185&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">21219183</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Berke IC, Modis Y. DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature. Embo J. 2012;31(4):919&#x2013;931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3280545</ArticleId><ArticleId IdType="pubmed">22258621</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>